Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Neuroscience

A subscription to JoVE is required to view this content. Sign in or start your free trial.

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
 
Click here for the English version

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Article DOI: 10.3791/1955-v 15:23 min May 13th, 2010
May 13th, 2010

Chapters

Summary

Please note that all translations are automatically generated.

Click here for the English version.

Aptamers are short ribo-/deoxyribo-oligonucleotides selected by in-vitro evolution methods based on affinity for a specific target. Aptamers are molecular recognition tools with versatile therapeutic, diagnostic, and research applications. We demonstrate methods for selection of aptamers for amyloid β-protein, the causative agent of Alzheimer's disease.

Tags

Aptamers Amyloid β-protein Alzheimer's Disease Neurodegenerative Disorder Presymptomatic Diagnosis Early Diagnosis Effective Therapies Aβ Assemblies Synaptic Dysfunction Neuron Loss AD Etiology AD Pathogenesis Molecular Recognition Tools Antibodies Aptamers Advantages SELEX (systematic Evolution Of Ligands By Exponential Enrichment)
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter